Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06257576 · ClinicalTrials.gov registry record · Phase 3
Function of Tamsulosin in Older Males Undergoing Surgery with Indwelling Catheter
A Phase 3 study of Postoperative Urinary Tract Infection, sponsored by Emory University.
- Recruiting
- Registry status
- Phase 3
- Development phase
- 212
- Enrollment target
- 3
- Study locations
NCT06257576 is a Phase 3 study of Postoperative Urinary Tract Infection that is actively recruiting participants, run by Emory University. The registered enrollment target is 212 participants. The trial reports 3 study locations across 1 state.
The verdict
NCT06257576, a Phase 3 study of Postoperative Urinary Tract Infection, is actively recruiting participants, sponsored by Emory University.
- RECRUITING
- Registry status
- Phase 3
- Development phase
- 212 participants
- Enrollment target
- 3
- Study locations
Study Summary
This study is being done to answer the question: What is the impact of a medication called tamsulosin (also called Flomax) on the rate of postoperative urinary retention (POUR) and catheter-associated urinary tract infection (UTI)? One of the most common complications following surgery and associated with Foley catheters is post-operative urinary retention (POUR) after the catheter is removed. This is defined as being unable to urinate spontaneously within 8 hours following the removal of the indwelling Foley catheter (the catheter that sits in your bladder to drain urine after surgery). When this happens, it requires intermittent straight catheterization of the bladder (placing a temporary catheter in the bladder to drain the buildup of urine), which can cause a lot of discomfort and anxiety, as well as increase the risk of catheter-associated urinary tract infection (CAUTI).
Conditions Studied
Interventions
- OTHER Control Group
- DRUG Tamsulosin
Study Locations (3)
Georgia
- Emory Saint Joseph's Hospital - Atlanta
- Emory University Hospital Midtown - Atlanta
- Emory University Hospital (EUH) - Atlanta
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 212 participants |
| Start Date | 2024-02-26 |
| Est. Completion | 2026-02 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06257576
The ClinicalTrials.gov registry entry for NCT06257576 describes a study currently listed as recruiting, categorized as Phase 3. The registered enrollment target is 212 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Emory University, which has 1,208 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Postoperative Urinary Tract Infection appearing as the primary indexed condition, and to 2 interventions - of which Control Group is the first listed.
NCT06257576 reports 3 study locations spanning 1 distinct geographic area - top geographies include Georgia.
Frequently Asked Questions
What is clinical trial NCT06257576 about?
NCT06257576 is a clinical study titled "Function of Tamsulosin in Older Males Undergoing Surgery with Indwelling Catheter". This study is being done to answer the question: What is the impact of a medication called tamsulosin (also called Flomax) on the rate of postoperative urinary retention (POUR) and catheter-associated urinary tract infection (UTI)? One of the most common complications following surgery and associate...
What is the current status of trial NCT06257576?
This trial is currently recruiting. It is a Phase 3 study. The enrollment target is 212 participants. The study started on 2024-02-26. Estimated completion is 2026-02.
What conditions does trial NCT06257576 study?
This clinical trial studies the following conditions: Postoperative Urinary Tract Infection.
What interventions are being tested in trial NCT06257576?
The interventions under investigation include: Control Group (OTHER), Tamsulosin (DRUG).
Who is sponsoring clinical trial NCT06257576?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06257576 being conducted?
This trial has 3 study locations across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Postoperative Urinary Tract Infection
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.